Angehefteter Tweet

🎉✨ Exciting Lab Update! ✨🎉
We’re thrilled to share that Associate Professor Richard Gordon and PhD candidate Aishwarya Mary Johnson have secured funding through the Pipeline Accelerator Scheme, an incredible initiative by Therapeutic Innovation Australia in partnership with Phenomics Australia and the National Deuteration Facility! 🧠💊
This support enables our team to access cutting-edge translational research infrastructure to screen therapeutic agents targeting Parkinson’s disease symptoms. This milestone is a testament to the passion, collaboration, and dedication of our lab to advancing medical research. 💪
A massive thank you to Therapeutic Innovation Australia and partners for empowering us to drive innovation in the fight against Parkinson’s. Together, we’re taking meaningful steps toward improving lives! 🌟
For more details, check out: Link
Here’s to breaking boundaries in science and making a difference! 🧬✨
#ParkinsonsResearch #TherapeuticInnovation #PipelineAccelerator #TranslationalResearch #Collaboration #Innovation #Teamwork #Neuroscience #MedicalResearch #QUT #TRI @TherapeuticInnovationAustralia @TRI @QUT @ParkinsonsQLD @PhenomicsAustralia @NationalDeuterationFacility @ParkinsonsAustralia @FightParkinsonsAU


English























